Research Groups

Early Detection and Prevention - Prevention and Implementation Group

Previous Publications - All Publications 2015-2011

1. Conway D.I., Brenner D.R., McMahon A.D., Macpherson L.M., Agudo A., Ahrens W., Bosetti C., Brenner H., Castellsague X., Chen C., Curado M.P., Curioni O.A., Dal Maso L., Daudt A.W., de Gois Filho J.F., D'Souza G., Edefonti V., Fabianova E., Fernandez L., Franceschi S., Gillison M., Hayes R.B., Healy C.M., Herrero R., Holcatova I., Jayaprakash V., Kelsey K., Kjaerheim K., Koifman S., La Vecchia C., Lagiou P., Lazarus P., Levi F., Lissowska J., Luce D., Macfarlane T.V., Mates D., Matos E., McClean M., Menezes A.M., Menvielle G., Merletti F., Morgenstern H., Moysich K., Muller H., Muscat J., Olshan A.F., Purdue M.P., Ramroth H., Richiardi L., Rudnai P., Schantz S., Schwartz S.M., Shangina O., Simonato L., Smith E., Stucker I., Sturgis E.M., Szeszenia-Dabrowska N., Talamini R., Thomson P., Vaughan T.L., Wei Q., Winn D.M., Wunsch-Filho V., Yu G.P., Zhang Z.F., Zheng T., Znaor A., Boffetta P., Chuang S.C., Ghodrat M., Amy Lee Y.C., Hashibe M., Brennan P. (2015) Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries International journal of cancer; 136(5):1125-1139. PMID: 24996155

2. Arrossi S., Thouyaret L., Herrero R., Campanera A., Magdaleno A., Cuberli M., Barletta P., Laudi R., Orellana L. (2015) Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial Lancet Glob.Health; 3(2):e85-e94. PMID: 25617202

3. Toporcov T.N., Znaor A., Zhang Z.F., Yu G.P., Winn D.M., Wei Q., Vilensky M., Vaughan T., Thomson P., Talamini R., Szeszenia-Dabrowska N., Sturgis E.M., Smith E., Shangina O., Schwartz S.M., Schantz S., Rudnai P., Richiardi L., Ramroth H., Purdue M.P., Olshan A.F., Eluf-Neto J., Muscat J., Moyses R.A., Morgenstern H., Menezes A., McClean M., Matsuo K., Mates D., Macfarlane T.V., Lissowska J., Levi F., Lazarus P., La Vecchia C., Lagiou P., Koifman S., Kjaerheim K., Kelsey K., Holcatova I., Herrero R., Healy C., Hayes R.B., Franceschi S., Fernandez L., Fabianova E., Daudt A.W., Curioni O.A., Maso L.D., Curado M.P., Conway D.I., Chen C., Castellsague X., Canova C., Cadoni G., Brennan P., Boccia S., Antunes J.L., Ahrens W., Agudo A., Boffetta P., Hashibe M., Lee Y.C., Filho V.W. (2015) Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium Int.J Epidemiol.; 44(1):169-185. PMID: 25613428

4. Porras C., Hildesheim A., Gonzalez P., Schiffman M., Rodriguez A.C., Wacholder S., Jimenez S., Quint W., Guillen D., Kreimer A.R., Herrero R. (2015) Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing Journal of the National Cancer Institute; 107(1):. PMID: 25479804

5. Almonte M., Ferreccio C., Luciani S., Gonzales M., Delgado J.M., Santos C., Alvarez M., Cuzick J., Sasieni P. (2015) Visual Inspection after Acetic Acid (VIA) Is Highly Heterogeneous in Primary Cervical Screening in Amazonian Peru PLoS.One.; 10(1):e0115355. PMID: 25635965

6. Lang Kuhs K.A., Gonzalez P., Rodriguez A.C., Van Doorn L.J., Schiffman M., Struijk L., Chen S., Quint W., Lowy D.R., Porras C., DelVecchio C., Jimenez S., Safaeian M., Schiller J.T., Wacholder S., Herrero R., Hildesheim A., Kreimer A.R. (2014) Reduced Prevalence of Vulvar HPV16/18 Infection Among Women Who Received the HPV16/18 Bivalent Vaccine: A Nested Analysis Within the Costa Rica Vaccine Trial Journal of infectious diseases; 210(12):1890-1899. PMID: 24958910

7. Herrero R., Park J.Y., Forman D. (2014) The fight against gastric cancer - the IARC Working Group report Best.Pract.Res Clin Gastroenterol; 28(6):1107-1114. PMID: 25439075

8. Park J.Y., von Karsa L., Herrero R. (2014) Prevention strategies for gastric cancer: a global perspective Clin Endosc.; 47(6):478-489. PMID: 25505712

9. Bedoya A.M., Tate D.J., Baena A., Cordoba C.M., Borrero M., Pareja R., Rojas F., Patterson J.R., Herrero R., Zea A.H., Sanchez G.I. (2014) Immunosuppression in cervical cancer with special reference to arginase activity Gynecol.Oncol; 135(1):74-80. PMID: 25084511

10. Campos N.G., Burger E.A., Sy S., Sharma M., Schiffman M., Rodriguez A.C., Hildesheim A., Herrero R., Kim J.J. (2014) An updated natural history model of cervical cancer: derivation of model parameters American journal of epidemiology; 180(5):545-555. PMID: 25081182

11. Herrero R., Parsonnet J., Greenberg E.R. (2014) Prevention of gastric cancer JAMA; 312(12):1197-1198. PMID: 25247512

12. Lang Kuhs K.A., Porras C., Schiller J.T., Rodriguez A.C., Schiffman M., Gonzalez P., Wacholder S., Ghosh A., Li Y., Lowy D.R., Kreimer A.R., Poncelet S., Schussler J., Quint W., Van Doorn L.J., Sherman M.E., Sidawy M., Herrero R., Hildesheim A., Safaeian M. (2014) Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates Am.J.Epidemiol.; 180(6):599-607. PMID: 25139208

13. Rollan A., Arab J.P., Camargo M.C., Candia R., Harris P., Ferreccio C., Rabkin C.S., Gana J.C., Cortes P., Herrero R., Duran L., Garcia A., Toledo C., Espino A., Lustig N., Sarfatis A., Figueroa C., Torres J., Riquelme A. (2014) Management of Helicobacter pylori infection in Latin America: A Delphi technique-based consensus World Journal of Gastroenterology : WJG; 20(31):10969-10983. PMID: 25152601

14. Lazcano-Ponce E., Stanley M., Munoz N., Torres L., Cruz-Valdez A., Salmeron J., Rojas R., Herrero R., Hernandez-Avila M. (2014) Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months Vaccine; 32(6):725-732. PMID: 24355090

15. Ronco G., Dillner J., Elfstrom K.M., Tunesi S., Snijders P.J., Arbyn M., Kitchener H., Segnan N., Gilham C., Giorgi-Rossi P., Berkhof J., Peto J., Meijer C.J. (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials Lancet; 383(9916):524-532. PMID: 24192252

16. Leoncini E., Ricciardi W., Cadoni G., Arzani D., Petrelli L., Paludetti G., Brennan P., Luce D., Stucker I., Matsuo K., Talamini R., La Vecchia C., Olshan A.F., Winn D.M., Herrero R., Franceschi S., Castellsague X., Muscat J., Morgenstern H., Zhang Z.F., Levi F., Dal Maso L., Kelsey K., McClean M., Vaughan T.L., Lazarus P., Purdue M.P., Hayes R.B., Chen C., Schwartz S.M., Shangina O., Koifman S., Ahrens W., Matos E., Lagiou P., Lissowska J., Szeszenia-Dabrowska N., Fernandez L., Menezes A., Agudo A., Daudt A.W., Richiardi L., Kjaerheim K., Mates D., Betka J., Yu G.P., Schantz S., Simonato L., Brenner H., Conway D.I., Macfarlane T.V., Thomson P., Fabianova E., Znaor A., Rudnai P., Healy C., Boffetta P., Chuang S.C., Lee Y.C., Hashibe M., Boccia S. (2014) Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium European journal of epidemiology; 29(1):35-48. PMID: 24271556

17. Chen A.A., Heideman D.A., Boon D., Chen Z., Burk R.D., De Vuyst H., Gheit T., Snijders P.J., Tommasino M., Franceschi S., Clifford G.M. (2014) Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer Virology; 356-362. PMID: 24314666

18. Robbins H.A., Kemp T.J., Porras C., Rodriguez A.C., Schiffman M., Wacholder S., Gonzalez P., Schiller J., Lowy D., Poncelet S., Esser M., Matys K., Hildesheim A., Pinto L.A., Herrero R., Safaeian M. (2014) Comparison of antibody responses to human papillomavirus vaccination as measured by three assays Frontiers in oncology; 328. PMID: 24455487

19. Anantharaman D., Chabrier A., Gaborieau V., Franceschi S., Herrero R., Rajkumar T., Samant T., Mahimkar M.B., Brennan P., McKay J.D. (2014) Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India PLoS ONE; 9(2):e88240. PMID: 24505444

20. Robbins H.A., Li Y., Porras C., Pawlita M., Ghosh A., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T.J., Gonzalez P., Schiller J., Lowy D., Esser M., Matys K., Quint W., Van Doorn L.J., Herrero R., Pinto L.A., Hildesheim A., Waterboer T., Safaeian M. (2014) Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus BMC.Infect Dis; 120. PMID: 24588945

21. Guevara E., Baena A., Almonte M., Salaza J.E., Gaviria A., Sanchez G.I. (2014) Revista Facultad Nacional de Salud Publica; 32(2):54-60.

22. Park J.Y., Forman D., Greenberg E.R., Herrero R. (2013) Helicobacter pylori Eradication in the Prevention of Gastric Cancer: Are More Trials Needed? Curr Oncol Rep.; 15(6):517-525. PMID: 24101366

23. Safaeian M., Porras C., Pan Y., Kreimer A., Schiller J.T., Gonzalez P., Lowy D.R., Wacholder S., Schiffman M., Rodriguez A.C., Herrero R., Kemp T., Shelton G., Quint W., Van Doorn L.J., Hildesheim A., Pinto L.A. (2013) Durable antibody responses following one dose of the bivalent human papillomavirus l1 virus-like particle vaccine in the costa rica vaccine trial Cancer Prev Res.(Phila); 6(11):1242-1250. PMID: 24189371

24. Lang Kuhs K.A., Gonzalez P., Struijk L., Castro F., Hildesheim A., Van Doorn L.J., Rodriguez A.C., Schiffman M., Quint W., Lowy D.R., Porras C., DelVecchio C., Katki H.A., Jimenez S., Safaeian M., Schiller J., Solomon D., Wacholder S., Herrero R., Kreimer A.R. (2013) Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica J Infect.Dis.; 208(10):1643-1652. PMID: 24014882

25. Rodriguez A.C., Solomon D., Herrero R., Hildesheim A., Gonzalez P., Wacholder S., Porras C., Jimenez S., Schiffman M. (2013) Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment Am.J Epidemiol; 178(5):752-760. PMID: 23843026

26. De Vuyst H., Chung M.H., Baussano I., Mugo N.R., Tenet V., van Kemenade F.J., Rana F.S., Sakr S.R., Meijer C.J., Snijders P.J., Franceschi S. (2013) Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya Int.J Cancer; 133(6):1441-1446. PMID: 23444059

27. Safaeian M., Kemp T.J., Pan D.Y., Porras C., Rodriguez A.C., Schiffman M., Cortes B., Katki H., Wacholder S., Schiller J.T., Gonzalez P., Penrose K., Lowy D.R., Quint W., Van Doorn L.J., Herrero R., Hildesheim A., Pinto L.A. (2013) Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial Hum Vaccin.Immunother.; 9(7):1399-1406. PMID: 23571174

28. Morgan D.R., Torres J., Sexton R., Herrero R., Salazar-Martinez E., Greenberg E.R., Bravo L.E., Dominguez R.L., Ferreccio C., Lazcano-Ponce E.C., Meza-Montenegro M.M., Pena E.M., Pena R., Correa P., Martinez M.E., Chey W.D., Valdivieso M., Anderson G.L., Goodman G.E., Crowley J.J., Baker L.H. (2013) Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities JAMA; 309(6):578-586. PMID: 23403682

29. Porras C., Nodora J., Sexton R., Ferreccio C., Jimenez S., Dominguez R.L., Cook P., Anderson G., Morgan D.R., Baker L.H., Greenberg E.R., Herrero R. (2013) Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701) Cancer causes & control : CCC; 24(2):209-215. PMID: 23263777

30. Torres J., Correa P., Ferreccio C., Hernandez-Suarez G., Herrero R., Cavazza-Porro M., Dominguez R., Morgan D. (2013) Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America Cancer causes & control : CCC; 24(2):249-256. PMID: 23224271

31. Nascimento C., De Vuyst H. (2013) Prevalence and type distribution of HPV in carcinoma and intraepithelial neoplasia of the vulva and vagina: a meta-analysis HPV Today; 12-13.

32. Herrero R., Quint W., Hildesheim A., Gonzalez P., Struijk L., Katki H.A., Porras C., Schiffman M., Rodriguez A.C., Solomon D., Jimenez S., Schiller J.T., Lowy D.R., Van Doorn L.J., Wacholder S., Kreimer A.R. (2013) Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica PLoS ONE; 8(7):e68329. PMID: 23873171

33. Herrero R. (2013) HPV and Cervical Cancer ; .

34. Lin S.W., Ghosh A., Porras C., Markt S.C., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T.J., Pinto L.A., Gonzalez P., Wentzensen N., Esser M.T., Matys K., Meuree A., Quint W., Van Doorn L.J., Herrero R., Hildesheim A., Safaeian M. (2013) HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays PLoS ONE; 8(1):e53067. PMID: 23301022

35. Bedoya A.M., Jaramillo R., Baena A., Castano J., Olaya N., Zea A.H., Herrero R., Sanchez G.I. (2013) Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer Cancer Microenviron.; 6(1):69-77. PMID: 22290207

36. Gonzalez P., Cortes B., Quint W., Kreimer A.R., Porras C., Rodriguez A.C., Jimenez S., Herrero R., Struijk L., Hildesheim A., Melchers W. (2012) Evaluation of the FTA carrier device for human papillomavirus testing in developing countries Journal of clinical microbiology; 50(12):3870-3876. PMID: 22993174

37. Kemp T.J., Safaeian M., Hildesheim A., Pan Y., Penrose K.J., Porras C., Schiller J.T., Lowy D.R., Herrero R., Pinto L.A. (2012) Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix((R)) Vaccine; 31(1):165-170. PMID: 23123024

38. Li Q., Chuang S.C., Eluf-Neto J., Menezes A., Matos E., Koifman S., Wunsch-Filho V., Fernandez L., Daudt A.W., Curado M.P., Winn D.M., Franceschi S., Herrero R., Castellsague X., Morgenstern H., Zhang Z.F., Lazarus P., Muscat J., McClean M., Kelsey K.T., Hayes R.B., Purdue M.P., Schwartz S.M., Chen C., Benhamou S., Olshan A.F., Yu G., Schantz S., Ferro G., Brennan P., Boffetta P., Hashibe M. (2012) Vitamin or mineral supplement intake and the risk of head and neck cancer: pooled analysis in the INHANCE consortium International journal of cancer; 131(7):1686-1699. PMID: 22173631

39. Rodriguez A.C., Schiffman M., Herrero R., Hildesheim A., Bratti C., Sherman M.E., Solomon D., Guillen D., Alfaro M., Morales J., Hutchinson M., Cheung L., Wacholder S., Burk R.D. (2012) Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3 International journal of cancer; 131(8):1874-1881. PMID: 22213126

40. Castro F.A., Quint W., Gonzalez P., Katki H.A., Herrero R., Van Doorn L.J., Schiffman M., Struijk L., Rodriguez A.C., Del Vecchio C., Lowy D.R., Porras C., Jimenez S., Schiller J., Solomon D., Wacholder S., Hildesheim A., Kreimer A.R. (2012) Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica Journal of infectious diseases; 206(7):1103-1110. PMID: 22850119

41. Safaeian M., Ghosh A., Porras C., Lin S.W., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T., Gonzalez P., Wentzensen N., Esser M., Meuree A., Matys K., Quint W., Van Doorn L.J., Sherman M.E., Herrero R., Pinto L.A., Hildesheim A. (2012) Direct Comparison of HPV16 Serological Assays Used to Define HPV-Naive Women in HPV Vaccine Trials Cancer epidemiology, biomarkers & prevention; 21(9):1547-1554. PMID: 22752082

42. Santesso N., Schunemann H., Blumenthal P., De Vuyst H., Gage J., Garcia F., Jeronimo J., Lu R., Luciani S., Quek S.C., Awad T., Broutet N. (2012) World Health Organization Guidelines: Use of cryotherapy for cervical intraepithelial neoplasia International journal of gynaecology and obstetrics; 118(2):97-102. PMID: 22727415

43. Kreimer A.R., Schiffman M., Herrero R., Hildesheim A., Gonzalez P., Burk R.D., Porras C., Sherman M.E., Demuth F., Cheung L., Bratti C., Cecilia Rodriguez A. (2012) Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment International journal of cancer; 131(1):211-218. PMID: 21823117

44. Kemp T.J., Safaeian M., Miner S., Williams M.C., Rodriguez A.C., Herrero R., Hildesheim A., Pinto L.A. (2012) Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels Frontiers in oncology; 61. PMID: 22737669

45. Kreimer A.R., Gonzalez P., Katki H.A., Porras C., Schiffman M., Rodriguez A.C., Solomon D., Jimenez S., Schiller J.T., Lowy D.R., Van Doorn L.J., Struijk L., Quint W., Chen S., Wacholder S., Hildesheim A., Herrero R. (2011) Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial Lancet oncology; 12(9):862-870. PMID: 21865087

46. Greenberg E.R., Anderson G.L., Morgan D.R., Torres J., Chey W.D., Bravo L.E., Dominguez R.L., Ferreccio C., Herrero R., Lazcano-Ponce E.C., Meza-Montenegro M.M., Pena R., Pena E.M., Salazar-Martinez E., Correa P., Martinez M.E., Valdivieso M., Goodman G.E., Crowley J.J., Baker L.H. (2011) 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial Lancet; 378(9790):507-514. PMID: 21777974

47. Herrero R., Wacholder S., Rodriguez A.C., Solomon D., Gonzalez P., Kreimer A.R., Porras C., Schussler J., Jimenez S., Sherman M.E., Quint W., Schiller J.T., Lowy D.R., Schiffman M., Hildesheim A. (2011) Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica Cancer Discovery; 1(5):408-419.